Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to families and caregivers.

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.

Joe is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.